Damian J. Green, MD
Seattle Cancer Care Alliance
University of Washington School of Medicine
Fred Hutchinson Cancer Research Center
Bone marrow transplantation, cellular immunotherapy, multiple myeloma, amyloidosis, Waldenström's Macroglobulinemia
We’re not going to stop until we have therapies that cure every patient.”
What do you enjoy most about being an oncologist?
My life’s work has focused on developing new therapies for cancers of the blood and treating patients who are coping with those diseases. It’s so exciting to move discoveries from the research lab to the clinic in real time. One of the best parts of my job is being able to fine-tune care as we go, making it more effective and tolerable — so my patients can get back to doing what they love as soon as possible. It gives me hope that one day we can eradicate these cancers completely.
Specialties and clinical expertise
The branch of medicine a provider practices and their areas of focus
I am a hematologist-oncologist who treats patients with multiple myeloma and other cancers of the blood. I am a co-investigator on over 20 clinical trials and have published more than 75 scientific articles. In 2017, I was awarded a $3.2 million grant by the National Cancer Institute to test a new form of immunotherapy for multiple myeloma. I have also been a presenter at the annual conference for the American Society of Hematology.
What is your approach to care?
There are two important elements that inform everything I do. First, I believe it’s essential to create an authentic connection with you, understanding who you are outside your disease, what you wish for and what you value in life. Any recommendations I make about care are based on the interpersonal foundation we build together. Second, I’m committed to a team approach, partnering with other providers so we’re in agreement about what therapies will best serve your needs and goals.